Medicines Co's Cangrelor wins FDA approval after multiple setbacks
June 22, 2015 at 14:37 PM EDT
June 22 (Reuters) - The U.S. Food and Drug Administration approved Medicines Co's blood clot preventer Cangrelor on Monday, close to a decade after the drug first entered late-stage studies.
